日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials-The Ring Study and DREAM

达匹韦林阴道环试验(Ring 研究和 DREAM 研究)中血清转化女性的临床表现、治疗反应和病毒学结果

Steytler, John; van der Ryst, Elna; Craig, Charles; Van Baelen, Ben; Nuttall, Jeremy; van Niekerk, Neliëtte; Mellors, John; Parikh, Urvi; Wallis, Carole

Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction

达匹韦林阴道环用于降低1型人类免疫缺陷病毒感染风险的3期和3b期试验(阴道环研究和达匹韦林阴道环延长使用和监测试验)中病毒的特征分析

Steytler, John; Craig, Charles; van der Ryst, Elna; Van Baelen, Ben; Nuttall, Jeremy; van Niekerk, Neliëtte; Mellors, John; Parikh, Urvi; Wallis, Carole

Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)

对 HIV-1 血清阴性成人直肠给药达匹韦林/安慰剂凝胶的接受度 (MTN-026)

Bauermeister, José A; Tingler, Ryan C; Dominguez, Clara; Dunne, Eileen F; Hoesley, Craig; Ho, Ken; Johnson, Sherri; Lucas, Jonathan; Macagna, Nicole; Brown, Elizabeth; Gundacker, Holly; Peda, Melissa; Jacobson, Cindy E; Kramzer, Lindsay; Singh, Devika; Dezzutti, Charlene S; Ayudhya, Ratiya Pamela Kunjara Na; Marzinke, Mark A; Piper, Jeanna; Devlin, Bríd; Nuttall, Jeremy; McGowan, Ian; Hendrix, Craig W; Cranston, Ross D

A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)

一项随机、双盲、安慰剂对照的 1 期安全性和药代动力学研究,评估达匹韦林凝胶 (0.05%) 直肠给药对 HIV-1 血清阴性成年人的疗效 (MTN-026)

Cranston, Ross D; Brown, Elizabeth; Bauermeister, José; Dunne, Eileen F; Hoesley, Craig; Ho, Ken; Johnson, Sherri; Lucas, Jonathan; Dominguez-Islas, Clara; Gundacker, Holly; Peda, Melissa; Jacobson, Cindy E; Kramzer, Lindsay; Singh, Devika; Dezzutti, Charlene S; Kunjara Na Ayudhya, Ratiya Pamela; Brand, Rhonda M; Wang, Lin; Marzinke, Mark A; Piper, Jeanna; Devlin, Bríd; Nuttall, Jeremy; McGowan, Ian; Hendrix, Craig W

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

美国开展的达匹韦林长效阴道环的1期药代动力学和安全性研究

Liu, Albert Y; Dominguez Islas, Clara; Gundacker, Holly; Neradilek, Blazej; Hoesley, Craig; van der Straten, Ariane; Hendrix, Craig W; Beamer, May; Jacobson, Cindy E; McClure, Tara; Harrell, Tanya; Bunge, Katherine; Devlin, Brid; Nuttall, Jeremy; Spence, Patrick; Steytler, John; Piper, Jeanna M; Marzinke, Mark A

The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.

进入抑制剂 DS003 (BMS-599793):BMS-806 类似物,作为暴露前预防候选药物具有优异的活性

Herrera Carolina, Harman Sarah, Aldon Yoann, Rogers Paul, Armanasco Naomi, Ziprin Paul, Stieh Daniel, Nuttall Jeremy, Shattock Robin J

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

简讯:马拉维罗在黏膜组织中的抗HIV-1活性有限

Fletcher, Patricia; Herrera, Carolina; Armanasco, Naomi; Nuttall, Jeremy; Shattock, Robin J

The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides

以绵羊为模型进行候选杀微生物剂的临床前安全性和药代动力学评价

Holt, Jonathon D S; Cameron, David; Dias, Nicola; Holding, Jeremy; Muntendam, Alex; Oostebring, Freddy; Dreier, Peter; Rohan, Lisa; Nuttall, Jeremy

Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention

达匹韦林和马拉维罗单方及联合外用凝胶预防 HIV-1 的药效学活性

Dezzutti, Charlene S; Yandura, Sarah; Wang, Lin; Moncla, Bernard; Teeple, Elizabeth A; Devlin, Brid; Nuttall, Jeremy; Brown, Elizabeth R; Rohan, Lisa C